Last updated: August 25, 2021
Sponsor: Pakistan Institute of Living and Learning
Overall Status: Completed
Phase
3
Condition
Depression
Mood Disorders
Depression (Major/severe)
Treatment
N/AClinical Study ID
NCT03435744
PILL-DepSTAT-001
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- DSM-5 current major depressive episode
- Must currently be on an antidepressant and must have had a non-response to >2 oralantidepressant treatments in the current episode (including the one they are currentlytaking).
- Capacity to give informed consent
- Willing to use adequate contraception
- Give written informed consent
Exclusion
Exclusion Criteria:
- Primary psychotic or bipolar disorder
- History of intolerance to statins or presence of any contraindication to statins
- Presence of any serious medical condition or neurological problem
- Presence of autoimmune or inflammatory disorder
- Alcohol or drug dependence
- Active suicidal ideation
- Pregnant or breast-feeding.
Study Design
Total Participants: 150
Study Start date:
January 01, 2019
Estimated Completion Date:
June 30, 2021
Connect with a study center
Civil Hospital
Hyderabad,
PakistanSite Not Available
Abbasi Shaheed Hospital
Karachi,
PakistanSite Not Available
Civil Hospital
Karachi, 75500
PakistanSite Not Available
Institute of Professional Psychology
Rawalpindi,
PakistanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.